SE9800806D0 - Användning av kollagenas - Google Patents

Användning av kollagenas

Info

Publication number
SE9800806D0
SE9800806D0 SE9800806A SE9800806A SE9800806D0 SE 9800806 D0 SE9800806 D0 SE 9800806D0 SE 9800806 A SE9800806 A SE 9800806A SE 9800806 A SE9800806 A SE 9800806A SE 9800806 D0 SE9800806 D0 SE 9800806D0
Authority
SE
Sweden
Prior art keywords
collagenase
disease
hand
dupuytren
ruptured
Prior art date
Application number
SE9800806A
Other languages
English (en)
Other versions
SE9800806L (sv
SE522723C2 (sv
Inventor
Thomas L Wegman
Original Assignee
Advance Biofactures Curacao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Biofactures Curacao filed Critical Advance Biofactures Curacao
Publication of SE9800806D0 publication Critical patent/SE9800806D0/sv
Publication of SE9800806L publication Critical patent/SE9800806L/sv
Publication of SE522723C2 publication Critical patent/SE522723C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
SE9800806A 1997-03-27 1998-03-12 Användning av kollagenas vid behandling av Dupuytrens sjukdom SE522723C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/826,015 US6086872A (en) 1997-03-27 1997-03-27 Amelioration of dupuytren's disease

Publications (3)

Publication Number Publication Date
SE9800806D0 true SE9800806D0 (sv) 1998-03-12
SE9800806L SE9800806L (sv) 1998-09-28
SE522723C2 SE522723C2 (sv) 2004-03-02

Family

ID=25245473

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9800806A SE522723C2 (sv) 1997-03-27 1998-03-12 Användning av kollagenas vid behandling av Dupuytrens sjukdom

Country Status (8)

Country Link
US (2) US6086872A (sv)
AU (1) AU733208B2 (sv)
DE (1) DE19813748A1 (sv)
DK (1) DK177324B1 (sv)
FR (2) FR2772273B1 (sv)
GB (1) GB2323530B (sv)
NO (1) NO981388L (sv)
SE (1) SE522723C2 (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
US6022539A (en) * 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
GB0306165D0 (en) * 2003-03-18 2003-04-23 Delta G Ltd Medical treatment
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
WO2006078870A2 (en) * 2005-01-21 2006-07-27 Advance Biofactures Corporation Methods for treating adhesive capsulitis
ITPD20050207A1 (it) * 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2008100833A2 (en) * 2007-02-13 2008-08-21 Auxilium International Holdings, Inc. Production of recombinant collagenases colg and colh in escherichia coli
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
EP2403523A1 (en) 2009-03-06 2012-01-11 Halozyme, Inc. Temperature sensitive mutants of matrix metalloprotease 1 und uses thereof
WO2010111525A2 (en) 2009-03-25 2010-09-30 Agee, John, M., Trustee Of The John M. Agee Trust Of August 15, 1996 Treatment of carpal tunnel syndrome by injection of the flexor retinaculum
EP2632446B1 (en) * 2010-10-30 2018-12-12 Oxford University Innovation Limited Treatment for dupuytren's disease
US10119131B2 (en) 2011-03-16 2018-11-06 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
ES2690568T3 (es) 2011-07-20 2018-11-21 Mediwound, Ltd. Extracto proteolítico de bromelaína para el tratamiento de trastornos del tejido conectivo
GB201119089D0 (en) 2011-11-04 2011-12-21 Isis Innovation Treatment of musculoskeletal fibroproliferative disorders
NZ766918A (en) 2012-01-12 2023-03-31 Auxilium Int Holdings Inc Clostridium histolyticum enzymes and methods for the use thereof
US20150079069A1 (en) * 2012-04-30 2015-03-19 Elastomics Ab Methods for modification of tissues
WO2014066622A2 (en) 2012-10-24 2014-05-01 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
WO2014107745A1 (en) 2013-01-07 2014-07-10 Halozyme, Inc. Metal sensitive mutants of matrix metalloproteases and uses thereof
EP2968484B1 (en) 2013-03-15 2020-11-25 BioSpecifics Technologies Corporation Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
EP3589204A1 (en) 2017-03-01 2020-01-08 Endo Ventures Limited Apparatus and method for assessing and treating cellulite
KR20240001279A (ko) * 2017-03-28 2024-01-03 엔도 벤쳐즈 리미티드 개선된 콜라게나제 생성 방법
CA3157517A1 (en) 2019-10-15 2021-04-22 The Johns Hopkins University Treatment of uterine fibroids using purified collagenase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
US5173295A (en) * 1990-10-05 1992-12-22 Advance Biofactures Of Curacao, N.V. Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5589171A (en) 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase

Also Published As

Publication number Publication date
DE19813748A1 (de) 1998-10-01
FR11C0033I1 (sv) 2011-09-23
FR11C0033I2 (fr) 2012-03-16
GB2323530B (en) 2001-10-10
DK40398A (da) 1998-09-28
DK177324B1 (da) 2013-01-07
SE9800806L (sv) 1998-09-28
GB2323530A (en) 1998-09-30
AU733208B2 (en) 2001-05-10
US6086872A (en) 2000-07-11
USRE39941E1 (en) 2007-12-18
SE522723C2 (sv) 2004-03-02
FR2772273B1 (fr) 2003-04-25
NO981388L (no) 1998-09-28
AU5966198A (en) 1998-10-01
NO981388D0 (no) 1998-03-26
FR2772273A1 (fr) 1999-06-18
GB9805050D0 (en) 1998-05-06

Similar Documents

Publication Publication Date Title
SE9800806L (sv) Användning av kollagenas
ATE369131T1 (de) Verwendung von agonisten des zentralen cannabinoid-rezeptors cb1
BR9306683A (pt) Adesivo proteináceo curado com aldeído
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
DE69529026D1 (de) Trehalose, ihre Herstellung und ihre Verwendung
ID16862A (id) Komposisi-komposisi elastomer dan metoda-metoda pembuatannya
ATE223431T1 (de) Derivate von dolastatin, dreen herstellung un verwendung
NO169657C (no) Fremgangsmaate for fremstilling av svovel-olefin-vulkaniseringsmiddel for naturlig og syntetisk gummi og anvendelse av dette
SE9502893D0 (sv) Användning av kollagenas
IT1285770B1 (it) Composti corticoidei
ATE113207T1 (de) Benzamid gegen kognitive erkrankungen.
DE69521595D1 (de) Optisch-aktives Benzothiepin-Derivate, ihre Herstellung und Verwendung
ID17199A (id) Mikro-organisme pengurai hidrokarbon yang mengandung halogen dan pemakaiannya
DE69532106D1 (de) Maltose Phospharylase, Trehalose Phophorylase, Plesiomonasstamm, und Herstellung von Trehalose
DE69420095D1 (de) Derivate von Polysacchariden, ihre Herstellung und Verwendung
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
DE69421743D1 (de) Silikongummi-Zusammensetzungen, Herstellung und Verwendung
ATE103594T1 (de) Fucosidase-inhibitoren.
NO955258D0 (no) Medisinsk anvendelse av enzymer
DE69604071D1 (de) Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung
DK1044014T3 (da) Middel til behandling af allergiske eller hypersensitivitets-tilstande
ATE94624T1 (de) Elastische, hydraulisch gedaempfte buchse mit radialer elastizitaet und entkoppelung der steifigkeiten.
ID23156A (id) Turunan-turunan amidina, proses pembuatan komposisi dan penggunaannya
ATE198192T1 (de) Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung
ATE132500T1 (de) 24r-scymnol, herstellung und verwendung

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: PRODUCT NAME: KOLLAGENAS CLOSTRIDIUM HISTOLYTICUM; REG. NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 1190022-2.L

SPCG Supplementary protection certificate granted

Free format text: PRODUCT NAME: KOLLAGENAS CLOSTRIDIUM HISTOLYTICUM; REG. NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 1190022-2

Expiry date: 20180313

Extension date: 20230312

NUG Patent has lapsed